You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • THU0441 Risk-Benefit of Co-Administered Traumeel® (TR14) and Zeel® (ZE14) Intra-Articular (IA) Injections in Patients with Moderate-to-Severe Pain Associated with OA of the Knee (OAK)

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Osteoarthritis
THU0441 Risk-Benefit of Co-Administered Traumeel® (TR14) and Zeel® (ZE14) Intra-Articular (IA) Injections in Patients with Moderate-to-Severe Pain Associated with OA of the Knee (OAK)

 

Online download statistics by month:

Online download statistics by month: June 2015 to February 2023

AbstractFullPdf
Jun 20151900
Jul 20151100
Aug 20152001
Sep 20153301
Oct 20152600
Nov 20156000
Dec 20151703
Jan 20164200
Feb 20162303
Mar 20163803
Apr 20162000
May 20164200
Jun 20163000
Jul 20162200
Aug 20168300
Sep 20167002
Oct 20166801
Nov 20163300
Dec 20162500
Jan 20175302
Feb 20175101
Mar 20176101
Apr 20175400
May 20176401
Jun 20176301
Jul 201712403
Aug 20177400
Sep 20179802
Oct 201711403
Nov 201721200
Dec 201710803
Jan 201818802
Feb 201816000
Mar 201815804
Apr 201810203
May 20189401
Jun 20189401
Jul 20188800
Aug 201810401
Sep 201810600
Oct 20189002
Nov 201815801
Dec 201812401
Jan 20199401
Feb 20196700
Mar 20199001
Apr 20198804
May 20196300
Jun 20196601
Jul 20195400
Aug 20195301
Sep 201910400
Oct 20196900
Nov 20198600
Dec 20197200
Jan 202010200
Feb 20204202
Mar 202011801
Apr 202011100
May 20204701
Jun 20205600
Jul 20208600
Aug 202012200
Sep 20206700
Oct 20208000
Nov 20209800
Dec 20206500
Jan 20215201
Feb 20215300
Mar 202110004
Apr 20214100
May 20213400
Jun 20211900
Jul 20211500
Aug 20214500
Sep 20212700
Oct 20216100
Nov 20216201
Dec 20216600
Jan 20226800
Feb 20227701
Mar 20228001
Apr 202211501
May 20225201
Jun 20224700
Jul 20227700
Aug 20227402
Sep 20226600
Oct 20228100
Nov 20228301
Dec 20223000
Jan 20234700
Feb 20235300
Total6649072